
DelSiTech and Tolmar International have announced that they have entered into a global license and development agreement, following a previous …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

